Beyond the Hype: Innovating Obesity Treatments for Real-World Impact

Life Sciences, Pharma, Biotech, Drug Discovery & Development,
  • Tuesday, May 20, 2025 | 11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central)
  • 60 min

The global obesity epidemic has driven demand for innovative treatments, creating a competitive and rapidly evolving landscape in obesity drug development. While media coverage has amplified interest and sensationalized the use of GLP-1 receptor agonists, gaps remain in addressing unmet needs and improving current approved treatments for patients1.

This webinar will explore the obesity drug landscape, highlighting how the industry is responding to leading therapies and identifying opportunities for future innovation. The expert speakers will discuss alternative mechanisms of action that expand therapeutic possibilities beyond GLP-1 receptor agonists, offering hope for more effective solutions.

Additionally, the expert speakers will examine critical operational challenges in obesity drug clinical trials, including recruitment hurdles, psychological barriers and the importance of holistic patient support. By integrating psychological care and addressing social stigmas, the standard of care for patients managing obesity can be improved.

Join this webinar to navigate the evolving obesity treatment landscape, uncover practical solutions to trial challenges and pave the way for more effective therapies.

Source: 1Gionfriddo, Michael R. et al. An analysis of national news coverage of semaglutide for weight loss. Journal of the American Pharmacists Association, Volume 65, Issue 1, 102297.

Speaker

Ana Gonzalez-Santis, PhD, Premier Research

Ana Gonzalez-Santis, PhD, PMP, Executive Director, Program Strategy, General Medicine, Premier Research

Ana Gonzalez-Santis is responsible for strategic planning, coordination, knowledge and expertise for projects and/or standalone consultative services in metabolism, cardiovascular, immunology and inflammation indications. In this role, Ana collaborates with other functions to design effective and efficient clinical trials/programs, bringing specific regulatory, medical/scientific and operational knowledge to the respective areas of focus.

With more than 28 years of extensive experience in clinical research, Ana has a diverse background in various therapeutic areas and indications such as metabolism, oncology, inflammation, dermatology, neuroscience, ophthalmology and cardiovascular as well as several rare diseases and pediatric RWE studies.

She has managed studies across Phases I-IV and has extensive experience overseeing large programs and study portfolios. This experience enables her to act as an escalation point to help teams and clients to find effective solutions and mitigation plans for risks and issues as they arise. Through her various roles in project management, clinical operations and commercial teams, Ana possesses an overall perspective on clinical research that helps customers define realistic goals and achieve success.

Ana holds a PhD in Biochemistry and Molecular Biology, with specializations in immunology and human genetics, and has been a certified Project Management Professional since 2010.

Message Presenter

Who Should Attend?

This webinar will benefit Managers and above at biotech and specialty pharma companies with job functions including, but not limited, to:

  • Drug development
  • Clinical operations
  • Medical affairs
  • Regulatory affairs
  • Project management

What You Will Learn

Attendees will gain insights into:

  • The obesity drug landscape and pipeline
  • Novel mechanisms of action being explored in obesity drug research
  • Ways to overcome hurdles in obesity clinical trials

Xtalks Partner

Premier Research

Premier Research, a global clinical research, product development, and consulting company, is dedicated to helping innovators transform life-changing ideas and breakthrough science into new medical treatments. We offer strategic solutions across the entire development lifecycle, from pre-clinical through commercialization, specializing in smart study design and full-service clinical trial management.

Leveraging technology and therapeutic expertise, we deliver clean, conclusive data with a focus on reducing development timelines, securing access to the right patients, and effectively navigating global regulations to ensure submission-ready results.

As an organization that puts patients first, we pride ourselves on helping customers answer the unmet needs of patients across a broad range of medical conditions. Visit premier-research.com.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account